NVO vs MSFT: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Microsoft Corp in 2026
NVO
Novo Nordisk A S
$45.51
MSFT
Microsoft Corp
$417.51
Key Metrics Comparison
| Metric | NVO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $197.39B | N/A | NVO |
| P/E Ratio | 10.43 | 24.56 | NVO |
| EPS (TTM) | $4.27 | $16.80 | MSFT |
| Revenue Growth | 0.2% | 0.2% | NVO |
| Gross Margin | 83.2% | 68.3% | NVO |
Analyze NVO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or MSFT a better investment?
Comparing NVO and MSFT: Novo Nordisk A S has a market cap of $197.39B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and MSFT?
NVO (Novo Nordisk A S) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or MSFT?
Based on P/E ratios, NVO trades at a lower multiple (10.4x vs 24.6x).
Which is growing faster: NVO or MSFT?
NVO has higher revenue growth at 0.2% vs 0.2% for MSFT.
Which company is more profitable: NVO or MSFT?
Novo Nordisk A S (NVO) has higher gross margins at 83.2% compared to 68.3% for MSFT.
Which is the larger company: NVO or MSFT?
Novo Nordisk A S (NVO) is larger with a market cap of $197.39B compared to N/A for MSFT.
Should I buy NVO or MSFT in 2026?
Both NVO and MSFT have investment merit. NVO trades at $45.51 while MSFT trades at $417.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and MSFT stock?
Key differences: Market Cap ($197.39B vs N/A), P/E Ratio (10.4x vs 24.6x), Revenue Growth (0.2% vs 0.2%), Gross Margin (83.2% vs 68.3%).